-
1
-
-
68049131240
-
Salvage therapy for Hodgkin's lymphoma
-
F. Quddus, and J.O. Armitage Salvage therapy for Hodgkin's lymphoma Cancer J 15 2009 161 163
-
(2009)
Cancer J
, vol.15
, pp. 161-163
-
-
Quddus, F.1
Armitage, J.O.2
-
2
-
-
0027404777
-
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
-
DOI 10.1016/0140-6736(93)92411-L
-
D.C. Linch, D. Winfield, and A.H. Goldstone Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial Lancet 341 1993 1051 1054 (Pubitemid 23114397)
-
(1993)
Lancet
, vol.341
, Issue.8852
, pp. 1051-1054
-
-
Linch, D.C.1
Winfield, D.2
Goldstone, A.H.3
Moir, D.4
Hancock, B.5
McMillan, A.6
Chopra, R.7
Milligan, D.8
Vaughan Hudson, G.9
-
3
-
-
0037097044
-
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
-
DOI 10.1016/S0140-6736(02)08938-9
-
N. Schmitz, B. Pfistner, and M. Sextro Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Lancet 359 2002 2065 2071 (Pubitemid 34680969)
-
(2002)
Lancet
, vol.359
, Issue.9323
, pp. 2065-2071
-
-
Schmitz, N.1
Pfistner, B.2
Sextro, M.3
Sieber, M.4
Carella, A.M.5
Haenel, M.6
Boissevain, F.7
Zschaber, R.8
Muller, P.9
Kirchner, H.10
Lohri, A.11
Decker, S.12
Koch, B.13
Hasenclever, D.14
Goldstone, A.H.15
Diehl, V.16
-
5
-
-
0027324921
-
The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease
-
A.H. Goldstone, and A.K. McMillan The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease Ann Oncol 4 suppl 1 1993 21 27 (Pubitemid 23190844)
-
(1993)
Annals of Oncology
, vol.4
, Issue.SUPPL. 1
, pp. 21-27
-
-
Goldstone, A.H.1
McMillan, A.K.2
-
6
-
-
3342932858
-
Autologous bone marrow transplantation for lymphoma: A 15-year European bone marrow transplant registry (EBMT) experience of 3325 patients
-
A.K. Fielding, T. Philip, and A. Carella Autologous bone marrow transplantation for lymphoma: a 15-year European bone marrow transplant registry (EBMT) experience of 3325 patients ASH Annual Meeting Abstracts 84 1994 169
-
(1994)
ASH Annual Meeting Abstracts
, vol.84
, pp. 169
-
-
Fielding, A.K.1
Philip, T.2
Carella, A.3
-
7
-
-
33748526486
-
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation
-
DOI 10.1080/10428190500527769, PII X7L0307307456J73
-
N. Puig, J. de la Rubia, and M.J. Remigia Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation Leuk Lymphoma 47 2006 1488 1494 (Pubitemid 44364012)
-
(2006)
Leukemia and Lymphoma
, vol.47
, Issue.8
, pp. 1488-1494
-
-
Puig, N.1
De La Rubia, J.2
Remigia, M.J.3
Jarque, I.4
Martin, G.5
Cupelli, L.6
Sanz, G.F.7
Lorenzo, I.8
Sanz, J.9
Martinez, J.A.10
Jimenez, C.11
Sanz, M.A.12
-
8
-
-
5044251361
-
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma
-
DOI 10.1038/sj.bmt.1704637
-
E.H. Wang, Y.A. Chen, and S. Corringham High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma Bone Marrow Transplant 34 2004 581 587 (Pubitemid 39341537)
-
(2004)
Bone Marrow Transplantation
, vol.34
, Issue.7
, pp. 581-587
-
-
Wang, E.H.1
Chen, Y.A.2
Corringham, S.3
Bashey, A.4
Holman, P.5
Ball, E.D.6
Carrier, E.7
-
9
-
-
0031945421
-
Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease (HD): Comparative results with two CBV regimens and importance of disease status at transplant
-
R. Arranz, J.F. Tomas, and J.J. Gil-Fernandez Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease (HD): comparative results with two CBV regimens and importance of disease status at transplant Bone Marrow Transplant 21 1998 779 786 (Pubitemid 28190621)
-
(1998)
Bone Marrow Transplantation
, vol.21
, Issue.8
, pp. 779-786
-
-
Arranz, R.1
Tomas, J.F.2
Gil-Fernandez, J.J.3
Martinez-Chamorro, C.4
Granados, E.5
Alegre, A.6
Figuera, A.7
Vazquez, L.8
Camara, R.9
Fernandez-Ranada, J.M.10
-
10
-
-
0024215897
-
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian Study Group report
-
A.M. Carella, A.M. Congiu, and E. Gaozza High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report J Clin Oncol 6 1988 1411 1416 (Pubitemid 19089029)
-
(1988)
Journal of Clinical Oncology
, vol.6
, Issue.9
, pp. 1411-1416
-
-
Carella, A.M.1
Congin, A.M.2
Gaozza, E.3
Mazza, P.4
Ricci, P.5
Visani, G.6
Meloni, G.7
Cimino, G.8
Mangoni, L.9
Coser, P.10
Cetto, G.L.11
Cimino, R.12
Alessandrino, E.P.13
Brusamolino, E.14
Santini, G.15
Tura, S.16
Mandelli, F.17
Rizzoli, V.18
Bernasconi, C.19
-
11
-
-
0030938978
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
-
S.J. Horning, N.J. Chao, and R.S. Negrin High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices Blood 89 1997 801 813 (Pubitemid 27121273)
-
(1997)
Blood
, vol.89
, Issue.3
, pp. 801-813
-
-
Horning, S.J.1
Chao, N.J.2
Negrin, R.S.3
Hoppe, R.T.4
Long, G.D.5
Hu, W.W.6
Wong, R.M.7
Brown, B.W.8
Blume, K.G.9
-
12
-
-
0027360837
-
High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas
-
C. Patti, I. Majolino, and R. Scime High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas Eur J Haematol 51 1993 18 24 (Pubitemid 23283566)
-
(1993)
European Journal of Haematology
, vol.51
, Issue.1
, pp. 18-24
-
-
Patti, C.1
Majolino, I.2
Scime, R.3
Indovina, A.4
Vasta, S.5
Liberti, G.6
Gentile, S.7
Santoro, A.8
Pisa, R.9
Caronia, F.10
-
13
-
-
0029072508
-
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
-
D.E. Reece, M.J. Barnett, and J.D. Shepherd High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy Blood 86 1995 451 456
-
(1995)
Blood
, vol.86
, pp. 451-456
-
-
Reece, D.E.1
Barnett, M.J.2
Shepherd, J.D.3
-
14
-
-
0035281922
-
Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group
-
A. Sureda, R. Arranz, and A. Iriondo Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group J Clin Oncol 19 2001 1395 1404 (Pubitemid 32202546)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.5
, pp. 1395-1404
-
-
Sureda, A.1
Arranz, R.2
Iriondo, A.3
Carreras, E.4
Lahuerta, J.J.5
Garcia-Conde, J.6
Jarque, I.7
Caballero, M.D.8
Ferraa, C.9
Lopez, A.10
Garcia-Larana, J.11
Carrera, R.12
Carrera, D.13
Ruiz-Romero, M.D.14
Leon, A.15
Rifon, J.16
Diaz-Mediavilla, J.17
Mataix, R.18
Morey, M.19
Moraleda, J.M.20
Altes, A.21
Lopez-Guillermo, A.22
De La Serna, J.23
Fernandez-Ranada, J.M.24
Sierra, J.25
Conde, E.26
more..
-
15
-
-
0031158343
-
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: A prognostic model for treatment outcomes
-
C. Wheeler, C. Eickhoff, and A. Elias High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes Biol Blood Marrow Transplant 3 1997 98 106 (Pubitemid 127529983)
-
(1997)
Biology of Blood and Marrow Transplantation
, vol.3
, Issue.2
, pp. 98-106
-
-
Wheeler, C.1
Eickhoff, C.2
Elias, A.3
Ibrahim, J.4
Ayash, L.5
McCauley, M.6
Mauch, P.7
Schwartz, G.8
Eder, J.P.9
Mazanet, R.10
Ferrara, J.11
Rimm, I.J.12
Guinan, E.13
Bierer, B.14
Gilliland, G.15
Churchill, W.H.16
Ault, K.17
Parsons, S.18
Antman, K.19
Schnipper, L.20
Tepler, I.21
Gaynes, L.22
Frei III, E.23
Kadin, M.24
Antin, J.25
more..
-
16
-
-
70349207133
-
Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma
-
N.S. Majhail, R. Bajorunaite, and H.M. Lazarus Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma Br J Haematol 147 2009 129 139
-
(2009)
Br J Haematol
, vol.147
, pp. 129-139
-
-
Majhail, N.S.1
Bajorunaite, R.2
Lazarus, H.M.3
-
17
-
-
0025912707
-
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease
-
A. Kessinger, P.J. Bierman, and J.M. Vose High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease Blood 77 1991 2322 2325
-
(1991)
Blood
, vol.77
, pp. 2322-2325
-
-
Kessinger, A.1
Bierman, P.J.2
Vose, J.M.3
-
18
-
-
0025991771
-
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease
-
D.E. Reece, M.J. Barnett, and J.M. Connors Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 9 1991 1871 1879
-
(1991)
J Clin Oncol
, vol.9
, pp. 1871-1879
-
-
Reece, D.E.1
Barnett, M.J.2
Connors, J.M.3
-
19
-
-
0029918551
-
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy
-
P.J. Bierman, J.R. Anderson, and M.B. Freeman High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy Ann Oncol 7 1996 151 156 (Pubitemid 26094879)
-
(1996)
Annals of Oncology
, vol.7
, Issue.2
, pp. 151-156
-
-
Bierman, P.J.1
Anderson, J.R.2
Freeman, M.B.3
Vose, J.M.4
Kessinger, A.5
Bishop, M.R.6
Armitage, J.O.7
-
20
-
-
0028310377
-
Detection and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease
-
R. Chopra, A.C. Wotherspoon, and S. Blair Detection and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease Br J Haematol 87 1994 647 649 (Pubitemid 24230041)
-
(1994)
British Journal of Haematology
, vol.87
, Issue.3
, pp. 647-649
-
-
Chopra, R.1
Wotherspoon, A.C.2
Blair, S.3
McMillan, A.K.4
Mills, W.5
Fielding, A.K.6
Linch, D.C.7
Goldstone, A.H.8
-
21
-
-
0032879243
-
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: A phase II study from the North American Marrow Transplant Group
-
D.R. Fleming, S.N. Wolff, and J.W. Fay Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group Leuk Lymphoma 35 1999 91 98 (Pubitemid 29454406)
-
(1999)
Leukemia and Lymphoma
, vol.35
, Issue.1-2
, pp. 91-98
-
-
Fleming, D.R.1
Wolff, S.N.2
Fay, J.W.3
Brown, R.A.4
Lynch, J.P.5
Bolwell, B.J.6
Stevens, D.A.7
Goodman, S.A.8
Greer, J.P.9
Stein, R.S.10
Pineiro, L.A.11
Collins, R.H.12
Goldsmith, L.J.13
Herzig, G.P.14
Herzig, R.H.15
-
22
-
-
0028941380
-
BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma
-
W. Mills, R. Chopra, and A. McMillan BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma J Clin Oncol 13 1995 588 595
-
(1995)
J Clin Oncol
, vol.13
, pp. 588-595
-
-
Mills, W.1
Chopra, R.2
McMillan, A.3
-
23
-
-
0033735870
-
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease
-
A. Argiris, S. Seropian, and D.L. Cooper High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease Ann Oncol 11 2000 665 672
-
(2000)
Ann Oncol
, vol.11
, pp. 665-672
-
-
Argiris, A.1
Seropian, S.2
Cooper, D.L.3
-
24
-
-
0033047988
-
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease
-
D.E. Reece, T.J. Nevill, and A. Sayegh Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease Bone Marrow Transplant 23 1999 1131 1138 (Pubitemid 29259669)
-
(1999)
Bone Marrow Transplantation
, vol.23
, Issue.11
, pp. 1131-1138
-
-
Reece, D.E.1
Nevill, T.J.2
Sayegh, A.3
Spinelli, J.J.4
Brockington, D.A.5
Barnett, M.J.6
Klingemann, H.-G.7
Connors, J.M.8
Nantel, S.H.9
Shepherd, J.D.10
Sutherland, H.J.11
Voss, N.J.S.12
Fairey, R.N.13
O'Reilly, S.E.14
Phillips, G.L.15
-
25
-
-
19244370150
-
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies
-
E.P. Alessandrino, P. Bernasconi, and A. Colombo Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies Bone Marrow Transplant 25 2000 309 313 (Pubitemid 30103021)
-
(2000)
Bone Marrow Transplantation
, vol.25
, Issue.3
, pp. 309-313
-
-
Alessandrino, E.P.1
Bernasconi, P.2
Colombo, A.3
Caldera, D.4
Martinelli, G.5
Vitulo, P.6
Malcovati, L.7
Nascimbene, C.8
Varettoni, M.9
Volpini, E.10
Klersy, C.11
Bernasconi, C.12
-
26
-
-
0027287418
-
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease
-
N. Schmitz, B. Glass, and P. Dreger High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease Ann Hematol 66 1993 251 256 (Pubitemid 23179049)
-
(1993)
Annals of Hematology
, vol.66
, Issue.5
, pp. 251-256
-
-
Schmitz, N.1
Glass, B.2
Dreger, P.3
Haferlach, T.4
Horst, H.-A.5
Ollech-Chwoyka, J.6
Suttorp, M.7
Gassmann, W.8
Loffler, H.9
-
27
-
-
0025215447
-
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: A dose-finding study
-
C. Wheeler, J.H. Antin, and W.H. Churchill Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study J Clin Oncol 8 1990 648 656 (Pubitemid 20127248)
-
(1990)
Journal of Clinical Oncology
, vol.8
, Issue.4
, pp. 648-656
-
-
Wheeler, C.1
Antin, J.H.2
Churchill, W.H.3
Come, S.E.4
Smith, B.R.5
Bubley, G.J.6
Rosenthal, D.S.7
Rappaport, J.M.8
Ault, K.A.9
Schnipper, L.E.10
Eder, J.P.11
-
28
-
-
0036569511
-
Autologous transplantation for aggressive non-Hodgkin's lymphoma: Results of a randomized trial evaluating graft source and minimal residual disease
-
DOI 10.1200/JCO.2002.09.138
-
J.M. Vose, G. Sharp, and W.C. Chan Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease J Clin Oncol 20 2002 2344 2352 (Pubitemid 34441662)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.9
, pp. 2344-2352
-
-
Vose, J.M.1
Sharp, G.2
Chan, W.C.3
Nichols, C.4
Loh, K.5
Inwards, D.6
Rifkin, R.7
Bierman, P.J.8
Lynch, J.C.9
Weisenburger, D.D.10
Kessinger, A.11
Armitage, J.O.12
-
29
-
-
0030463127
-
Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors
-
DOI 10.1016/S0966-3274(96)80054-2
-
H.T. Hassan, M. Stockschlader, and B. Schleimer Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors Transpl Immunol 4 1996 319 323 (Pubitemid 27019627)
-
(1996)
Transplant Immunology
, vol.4
, Issue.4
, pp. 319-323
-
-
Hassan, H.T.1
Stockschlader, M.2
Schleimer, B.3
Kruger, W.4
Zander, A.R.5
-
30
-
-
0029934028
-
Immune recovery after autologous or rhG-CSF primed PBSC transplantation
-
M.C. Rosillo, F. Ortuno, and J.M. Moraleda Immune recovery after autologous or rhG-CSF primed PBSC transplantation Eur J Haematol 56 1996 301 307 (Pubitemid 26156995)
-
(1996)
European Journal of Haematology
, vol.56
, Issue.5
, pp. 301-307
-
-
Rosillo, M.C.1
Ortuno, F.2
Moraleda, J.M.3
Lozano, M.L.4
Heras, I.5
De Arriba, F.6
Vicente, V.7
-
31
-
-
0027374883
-
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients
-
P.J. Bierman, R.G. Bagin, and S. Jagannath High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients Ann Oncol 4 1993 767 773 (Pubitemid 23340088)
-
(1993)
Annals of Oncology
, vol.4
, Issue.9
, pp. 767-773
-
-
Bierman, P.J.1
Bagin, R.G.2
Jagannath, S.3
Vose, J.M.4
Spitzer, G.5
Kessinger, A.6
Dicke, K.A.7
Armitage, J.O.8
-
32
-
-
35148893207
-
Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution
-
DOI 10.1080/10428190701573265, PII 782744583
-
C. Martinez, O. Salamero, and L. Arenillas Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: long-term outcome of 61 patients from a single institution Leuk Lymphoma 48 2007 1968 1975 (Pubitemid 47542983)
-
(2007)
Leukemia and Lymphoma
, vol.48
, Issue.10
, pp. 1968-1975
-
-
Martinez, C.1
Salamero, O.2
Arenillas, L.3
Duque, J.4
Lopez-Guillermo, A.5
Rovira, M.6
Urbano-Ispizua, A.7
Fernandez-Aviles, F.8
Carreras, E.9
Montserrat, E.10
-
33
-
-
0027534424
-
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients
-
R. Chopra, A.K. McMillan, and D.C. Linch The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 81 1993 1137 1145 (Pubitemid 23067347)
-
(1993)
Blood
, vol.81
, Issue.5
, pp. 1137-1145
-
-
Chopra, R.1
McMillan, A.K.2
Linch, D.C.3
Yuklea, S.4
Taghipour, G.5
Pearce, R.6
Patterson, K.G.7
Goldstone, A.H.8
-
34
-
-
0027409446
-
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant
-
M. Crump, A.M. Smith, and J. Brandwein High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant J Clin Oncol 11 1993 704 711 (Pubitemid 23105679)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.4
, pp. 704-711
-
-
Crump, M.1
Smith, A.M.2
Brandwein, J.3
Couture, F.4
Sherret, H.5
Sutton, D.M.C.6
Scott, J.G.7
McCrae, J.8
Murray, C.9
Pantalony, D.10
Sutcliffe, S.B.11
Keating, A.12
-
35
-
-
0031967030
-
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)
-
DOI 10.1023/A:1008283909959
-
A. Josting, I. Katay, and U. Rueffer Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM) Ann Oncol 9 1998 289 295 (Pubitemid 28186799)
-
(1998)
Annals of Oncology
, vol.9
, Issue.3
, pp. 289-295
-
-
Josting, A.1
Katay, I.2
Rueffer, U.3
Winter, S.4
Tesch, H.5
Engert, A.6
Diehl, V.7
Wickramanayake, P.D.8
-
36
-
-
0034663188
-
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group
-
A. Josting, U. Rueffer, and J. Franklin Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group Blood 96 2000 1280 1286 (Pubitemid 30658456)
-
(2000)
Blood
, vol.96
, Issue.4
, pp. 1280-1286
-
-
Josting, A.1
Rueffer, U.2
Franklin, J.3
Sieber, M.4
Diehl, V.5
Engert, A.6
-
37
-
-
0027146193
-
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
-
A.P. Rapoport, J.M. Rowe, and P.A. Kouides One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome J Clin Oncol 11 1993 2351 2361
-
(1993)
J Clin Oncol
, vol.11
, pp. 2351-2361
-
-
Rapoport, A.P.1
Rowe, J.M.2
Kouides, P.A.3
-
38
-
-
0033008436
-
Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry
-
H.M. Lazarus, P.A. Rowlings, and M.J. Zhang Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry J Clin Oncol 17 1999 534 545 (Pubitemid 29075240)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.2
, pp. 534-545
-
-
Lazarus, H.M.1
Rowlings, P.A.2
Zhang, M.-J.3
Vose, J.M.4
Armitage, J.O.5
Bierman, P.J.6
Gajewski, J.L.7
Gale, R.P.8
Keating, A.9
Klein, J.P.10
Miller, C.B.11
Phillips, G.L.12
Reece, D.E.13
Sobocinski, K.A.14
Van Besien, K.15
Horowitz, M.M.16
-
39
-
-
0026439199
-
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
-
G.P. Canellos, J.R. Anderson, and K.J. Propert Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD N Engl J Med 327 1992 1478 1484
-
(1992)
N Engl J Med
, vol.327
, pp. 1478-1484
-
-
Canellos, G.P.1
Anderson, J.R.2
Propert, K.J.3
-
40
-
-
0027954426
-
Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
-
D.E. Reece, J.M. Connors, and J.J. Spinelli Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy Blood 83 1994 1193 1199 (Pubitemid 24062841)
-
(1994)
Blood
, vol.83
, Issue.5
, pp. 1193-1199
-
-
Reece, D.E.1
Connors, J.M.2
Spinelli, J.J.3
Barnett, M.J.4
Fairey, R.N.5
Klingemann, H.-G.6
Nantel, S.H.7
O'Reilly, S.8
Shepherd, J.D.9
Sutherland, H.J.10
Voss, N.11
Chan, K.-W.12
Phillips, G.L.13
|